The DOI matches its Crossref record.
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Abstract
In the last several years, the frequency and spectrum of antimicrobial-resistant infections have increased in both the hospital and the community. Certain infections that are essentially untreatable have begun to occur as epidemics both in the developing world and in institutional settings in the United States. The increasing frequency of drug resistance has been attributed to combinations of microbial characteristics, selective pressures of antimicrobial use, and societal and technologic changes that enhance the transmission of drug-resistant organisms. Antimicrobial resistance is resulting in increased morbidity, mortality, and health-care costs. Prevention and control of these infections will require new antimicrobial agents, prudent use of existing agents, new vaccines, and enhanced public health efforts to reduce transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Roberts, M. C. (1996) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1996.tb00251.x · Cited by 689
Trends in Infectious Diseases Mortality in the United States
Pinner, R. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270029027 · Cited by 487
Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance
Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014) · The Open Microbiology Journal · doi:10.2174/1874285801408010006 · Cited by 426
Vancomycin-resistant enterococci: why are they here, and where do they come from?
Bonten, M. J., Willems, R., & Weinstein, R. A. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00145-1 · Cited by 400
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Fluit, A. C., Jones, M. E., Schmitz, F.-J., Acar, J., Gupta, R., Verhoef, J., & the SENTRY Participants Group (2000) · Clinical Infectious Diseases · doi:10.1086/313710 · Cited by 312
Stojiljkovic, I., Kumar, V., & Srinivasan, N. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01175.x · Cited by 230
SUNDIN, G. W., & BENDER, C. L. (1996) · Molecular Ecology · doi:10.1111/j.1365-294x.1996.tb00299.x · Cited by 195
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186
“One of the first observations of bacteria adapting to anthropogenic compounds was the discovery of the spread of antibiotic resistance genes [28]; however, there is now indirect evidence of adaptation for many compounds.”
BackgroundGalactofuranose metabolism: a potential target for antimicrobial chemotherapy
Pedersen, L. L., & Turco, S. J. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180300021 · Cited by 169
Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150
Metlay, J. P., Camargo, C. A., MacKenzie, T., McCulloch, C., Maselli, J., Levin, S. K., Kersey, A., & Gonzales, R. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.03.022 · Cited by 118
Dunlop, R. H., McEwen, S. A., Meek, A. H., Clarke, R. C., Black, W. D., & Friendship, R. M. (1998) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(97)00095-0 · Cited by 109
Gebretekle, G. B., & Serbessa, M. K. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0101-z · Cited by 102
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku966 · Cited by 91
Nettleman, M. D., Chen, Y.-C., Chang, S.-C., Sun, C.-C., Yang, L.-S., Hsieh, W.-C., & Luh, K.-T. (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647628 · Cited by 88
A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle?
(2012) · Europe PMC (PubMed Central) · Cited by 82
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Emergency Medicine · doi:10.1067/s0196-0644(01)70087-x · Cited by 45
PATHOGENS RESISTANT TO ANTIMICROBIAL AGENTS
Fraimow, H. S., & Abrutyn, E. (1995) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30683-8 · Cited by 37
Daylight-stimulated antibacterial activity for sustainable bacterial detection and inhibition
Wu, Y., Chen, Q., Li, Q., Lu, H., Wu, X., Ma, J., & Gao, H. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01629d · Cited by 26
A mutation-induced drug resistance database (MdrDB)
Yang, Z., Ye, Z., Qiu, J., Feng, R., Li, D., Hsieh, C., Allcock, J., & Zhang, S. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00920-7 · Cited by 24
Flucytosine: Site of Action, Mechanism of Resistance and Use in Combination Therapy
Chandra, J., Mohammad, S., & Ghannoum, M. A. (2009) · Antimicrobial Drug Resistance · doi:10.1007/978-1-59745-180-2_27 · Cited by 6
Metadata
- Authors
- Cohen, M. L.
- Venue
- Science
- Published
- 1992-08-21
- Volume
- 257
- Issue
- 5073
- Pages
- 1050-1055
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2038014125
- Cited by
- 1,304
- References
- 0
- FWCI
- 58.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
